CoChat

The DOI matches its Crossref record; 199 of the 202 references it cites were found in a registry or an index.

The immunological landscape of primary biliary cholangitis: Mechanisms and therapeutic prospects

Ronca, Vincenzo, Davies, Scott P., Oo, Ye Htun, Lleo, Ana · 2025 · Hepatology

Abstract

Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease characterized by the progressive destruction of intrahepatic bile ducts, leading to fibrosis, and potentially cirrhosis. PBC has been considered a prototypical autoimmune condition, given the presence of specific autoantibodies and the immune response against well-defined mitochondrial autoantigens. Further evidence supports the interaction of immunogenetic and environmental factors in the etiology of PBC. An immunological attack on biliary epithelial cells with secondary failure of biliary transporters, eg, the anion exchange protein 2, is traditionally considered the primum movens. A recent hypothesis proposes a primary failure of biliary epithelial cells with the downregulation of anion exchange protein 2 secondary to epigenetic mechanisms (miR-506 overexpression), which then triggers the immunological storm. This highlights the secretory defect as the culprit and sustaining factor in the pathogenesis of PBC with ursodeoxycholic acid helping to restore this protective mechanism by promoting bicarbonate secretion and reducing bile acid toxicity. In this review, we aim to provide the most recent evidence on the immunopathogenesis of PBC. We will analyze the immune function of the biliary epithelium, assessing the immunomodulatory functions of the bile acids and the evidence of the immunological roles of the secretory pathways targeted by the current treatments.

Overview

Integrity signals

Registry

Crossref · 10.1097/hep.0000000000001225

Cites

199 of 199 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 202 references

Research works printed but not linked: 2

  1. Butler, 1995, Detection of M2 antibodies in patients with recurrent urinary tract infection using an ELISA and purified PBC specific antigens. Evidence for a molecular mimicry mechanism in the pathogenesis of primary biliary cirrhosis?, Biochem Mol Biol Int, 35, 473
  2. Gujral, 2004, Reduced oncotic necrosis in Fas receptor-deficient C57BL/6J-lpr mice after bile duct ligation, Hepatology, 40, 998

Cited by

See all 28

Metadata

Authors
Ronca, V., Davies, S. P., Oo, Y. H., & Lleo, A.
Affiliations
  • Humanitas University (IT)
  • University of Birmingham (GB)
  • University Hospitals Birmingham NHS Foundation Trust (GB)
  • Department of Biomedical Sciences, Humanitas University, Via Rita Levi, Pieve Emanuele, Milan, Italy
Venue
Hepatology
Published
2025-01-03
Volume
82
Issue
4
Pages
877-894
ISSN
  • 0270-9139 (ISSN-L)
  • 1527-3350
OpenAlex
W4406120002
Cited by
22
References
202
Citations by year
2026: 11 · 2025: 11
FWCI
3.23
Type
journal article
Language
en
Open access
closed
Locations
  • Hepatology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
  • Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
Keywords
primary biliary cirrhosis, immunopathogenesis, autoantibodies, mitochondrial autoantigens, cholangiocytes, miR-506, epigenetic regulation, bile acid secretion, bicarbonate secretion, bile acid toxicity, ursodeoxycholic acid, immunomodulation, cholestatic liver disease, liver fibrosis
MeSH terms
Bile Acids and Salts, Humans, Liver Cirrhosis, Biliary, Ursodeoxycholic Acid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The immunological landscape of primary biliary cholangitis: Mechanisms and therapeutic prospects. https://app.cochat.ai/papers/10.1097/hep.0000000000001225
The paper
Ronca, V., Davies, S. P., Oo, Y. H., & Lleo, A. (2025). The immunological landscape of primary biliary cholangitis: Mechanisms and therapeutic prospects. Hepatology. https://doi.org/10.1097/hep.0000000000001225

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.